Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli

Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):536-9. doi: 10.1007/BF02113435.

Abstract

The combination effect of subinhibitory and inhibitory concentrations of ceftazidime, granulocyte colony-stimulating factor (G-CSF) and polymorphonuclear leukocytes (PMNL) against Escherichia coli was investigated. PMNL obtained from healthy volunteers were incubated with different concentrations of G-CSF and ceftazidime for 180 min. The addition of 0.25 x MIC of ceftazidime or 1 x MIC significantly enhanced the bactericidal activity of PMNL. G-CSF at a concentration of 6,000 units/ml led to only a slight improvement in the bactericidal activity of PMNL. The combination of 6,000 units/ml G-CSF and ceftazidime in inhibitory as well as subinhibitory concentrations, however, showed a significant synergistic effect (p < 0.01) on the antibacterial activity of PMNL during the entire incubation period. Combinations of G-CSF and antibiotics could therefore be beneficial for infected patients, especially those with impaired cellular host defence.

MeSH terms

  • Adult
  • Ceftazidime / pharmacology*
  • Cephalosporins / pharmacology*
  • Drug Synergism
  • Escherichia coli / drug effects*
  • Female
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Neutrophils / physiology*
  • Phagocytosis

Substances

  • Cephalosporins
  • Granulocyte Colony-Stimulating Factor
  • Ceftazidime